General Data Protection Regulation: What It Means For US Healthcare/Life Science Companies (Part 3)
In the third post in a three-part series, experts at Foley Hoag address the effect of the EU’s General Data Protection Regulation on the healthcare and life sciences sector, including the specific categories of personal data relating to health and the exceptions to the regulation for scientific research.
🔒 Members Only · Cyber & Privacy BriefYou’ve reached the member portion of this brief.Members read the full analysis and the source documents in every case digest, six days a week.
$750/year